Transfection Kits

What Is Transfection?

Transfection is a laboratory technique used to deliver foreign nucleic acids—such as DNA, RNA, or CRISPR constructs—into eukaryotic cells. This method is fundamental for manipulating gene expression, studying cellular functions, and developing gene-based therapeutics. By enabling precise control of genetic activity, transfection facilitates deeper insights into disease mechanisms and the testing of potential treatments.

What Is Lung Transfection?

Lung transfection specifically refers to introducing genetic material into lung-derived cells, including epithelial carcinoma lines, fibroblasts, and other pulmonary cell types. These cells often have unique structural features like tight junctions and complex membrane compositions that make gene delivery challenging. Achieving efficient transfection in lung cells requires specialized reagents and optimized protocols to ensure high gene transfer rates with minimal toxicity.

Specialized Kits for Lung Cell Research

Our lung transfection kits are tailored for specific human and murine lung cell lines, providing researchers with reliable, high-performance tools for gene manipulation. Each kit includes cell-type–optimized formulations and detailed protocols designed to maximize efficiency while preserving cell viability. These products empower scientists to overcome the intrinsic challenges of lung cell transfection and accelerate discoveries in lung biology, cancer research, and respiratory disease modeling.

Lungs In Vivo Transfection Kit

Applications in Pulmonary Research

Lung tissue presents significant challenges for gene delivery due to its extensive surface area, complex cellular architecture, and active immune surveillance. The Lungs In Vivo Transfection Kit is optimized to address these obstacles, allowing for effective delivery of plasmid DNA, siRNA, shRNA, or mRNA to lung epithelial cells, alveolar macrophages, and vascular endothelial populations. This technology facilitates studies in pulmonary gene regulation, immune signaling, and the development of inhalable genetic therapeutics. It is particularly useful for evaluating gene function in models of acute lung injury, asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis.

Features and Experimental Advantages

This kit enables localized gene delivery while minimizing systemic toxicity, reducing the risk of off-target effects often encountered with less specific vectors. Its non-viral formulation avoids complications associated with immune recognition or insertional mutagenesis. The delivery vehicle is optimized for biodegradability, cellular uptake, and endosomal release, ensuring rapid and transient gene expression without long-term vector persistence. These properties make it well-suited for both mechanistic studies and therapeutic proof-of-concept experiments.

Compatibility and Administration

The Lungs In Vivo Transfection Kit can be used in various small animal models including mice and rats. It is compatible with both direct instillation (intratracheal and intranasal routes) for targeting respiratory epithelial surfaces, and systemic delivery (intravenous) when broader distribution is needed. The protocol includes detailed preparation and administration steps to ensure reproducibility and safety across different experimental setups. Researchers can tailor dosing and administration frequency based on the desired expression kinetics and tissue localization.

Use in Preclinical Therapeutic Development

This kit is increasingly applied in the development of gene therapies aimed at correcting or silencing disease-related genes in the lung. Preclinical studies using the Lungs In Vivo Transfection Kit have demonstrated its utility in delivering anti-inflammatory agents, modulating fibrosis-related pathways, and introducing reporter genes for real-time imaging of gene activity. Its rapid transfection timeline and high reproducibility support iterative screening of therapeutic constructs in vivo, making it a valuable asset for translational pulmonary research.

Read More Information: Lungs In Vivo Transfection Kit

Request Quote here: https://altogen.com/request-quote/

A549 Transfection Kit (Lung Carcinoma, CCL-185)

Relevance of A549 Cells in Lung Research

A549 cells are a widely used model for non-small cell lung cancer and retain many characteristics of alveolar epithelial cells. Their utility spans studies in tumor biology, respiratory toxicology, immune signaling, and therapeutic development. These cells are commonly used to investigate mechanisms of cell proliferation, apoptosis, metastasis, and resistance to lung cancer treatments. Because of their robust growth and responsiveness to molecular interventions, A549 cells serve as an essential platform for experimental gene modulation.

Transfection of A549 cells provides researchers with the ability to manipulate expression of key regulators involved in lung tumor progression and inflammatory signaling. Applications range from pathway dissection to drug screening, offering a window into both oncogenic transformation and therapeutic response mechanisms.

Technical Advantages of the A549 Transfection Kit

Lung epithelial carcinoma cells pose challenges for gene delivery due to their membrane characteristics and endocytic activity. The A549 Transfection Kit is engineered to overcome these limitations with a proprietary lipid formulation that enhances nucleic acid uptake and promotes efficient cytoplasmic release. This results in reliable gene expression or silencing while maintaining high levels of cell viability and morphological integrity.

The kit is optimized for use in multi-well formats and supports a wide range of experimental workflows including co-transfection, time-course analysis, and dose-response studies. Its streamlined protocol ensures consistent results without the need for custom optimization, allowing for rapid experimental setup and repeatability.

Applications in Lung Cancer Research

Transfection of A549 cells is central to lung cancer biology, particularly in the identification of molecular drivers of disease and the validation of therapeutic strategies. This model is frequently used in studies targeting cell cycle regulation, DNA repair, EGFR signaling, and apoptosis-related genes. Transfection-based experiments also allow for high-throughput screening of gene function using RNA interference or CRISPR technologies.

In toxicology and respiratory disease models, A549 cells provide insight into how lung epithelium responds to environmental insults, nanoparticles, and inflammatory cytokines. Genetic manipulation in these contexts helps define pathways of injury, repair, and cellular adaptation.

Read More Information: A549 Transfection Kit

Request Quote here: https://altogen.com/request-quote/

NCI-H441 Transfection Kit (Lung Carcinoma)

Relevance of NCI-H441 Cells in Lung Biology

NCI-H441 cells originate from human lung adenocarcinoma and exhibit many features of Clara cells, which are non-ciliated epithelial cells found in the bronchiolar airway. These cells express tight junction proteins and components involved in epithelial barrier function, making them valuable in modeling the alveolar-capillary interface, mucosal defense, and solute transport mechanisms of the lung. Their relevance extends beyond cancer biology into areas such as pulmonary drug absorption, surfactant metabolism, and epithelial response to environmental stressors.

In cancer research, NCI-H441 cells are utilized to study molecular pathways driving adenocarcinoma growth, epithelial-mesenchymal transition (EMT), and resistance to targeted therapies. Their gene expression profile makes them an effective model for exploring transcriptional regulation, tumor suppressor networks, and the impact of genetic perturbation on lung epithelial homeostasis.

Transfection Challenges and Kit Optimization

Pulmonary epithelial-derived tumor cells like NCI-H441 can be moderately difficult to transfect due to their membrane complexity, junctional integrity, and sensitivity to chemical agents. Standard reagents often result in low uptake and significant cytotoxicity, hindering experimental reproducibility.

The NCI-H441 Transfection Kit by Altogen Biosystems is specifically optimized for these conditions. Its proprietary lipid formulation enhances nucleic acid delivery by improving membrane penetration and facilitating endosomal escape, while maintaining the structural integrity and viability of delicate epithelial monolayers. This ensures robust gene expression or silencing without compromising experimental accuracy or cell function.

Applications in Lung Cancer and Pulmonary Research

Transfection of NCI-H441 cells allows researchers to manipulate gene expression and investigate key drivers of lung adenocarcinoma progression. These cells are commonly used to evaluate pathways involved in proliferation, cell adhesion, and epithelial polarity. Transfection enables studies involving RNA interference, overexpression systems, and CRISPR-based editing to dissect the molecular basis of oncogenesis, invasion, and resistance mechanisms.

Beyond oncology, NCI-H441 cells are frequently used in toxicology and pulmonary pharmacokinetics research. Their epithelial phenotype and barrier-forming properties support experiments investigating inhaled drug delivery, nanoparticle uptake, and gene-environment interactions. Transfection in these models enables real-time modulation of genes involved in surfactant production, inflammatory response, and oxidative stress.

Read More Information: NCI-H441 Transfection Kit

Request Quote here: https://altogen.com/request-quote/

NCI-H23 Transfection Reagent (Lung Adenocarcinoma)

Importance of NCI-H23 in Lung Cancer Research

NCI-H23 cells are derived from human lung adenocarcinoma and serve as a widely accepted model for studying non-small cell lung cancer (NSCLC). They are known for their epithelial morphology, moderate growth rate, and well-characterized mutational profile. These characteristics make NCI-H23 cells useful for exploring oncogene function, drug response mechanisms, and signal transduction pathways associated with lung tumorigenesis.

In addition to their applications in cancer biology, NCI-H23 cells are used to model gene expression dynamics, metabolic reprogramming, and stress response under variable treatment conditions. Their susceptibility to both targeted agents and conventional chemotherapeutics makes them a valuable system for testing gene-drug interactions and screening new therapeutic candidates.

Technical Considerations for Effective Transfection

Lung adenocarcinoma cells present a range of transfection challenges due to factors such as membrane rigidity, differential proliferation rates, and susceptibility to stress-induced cell death. The NCI-H23 Transfection Reagent addresses these limitations through an optimized lipid composition that enhances nucleic acid uptake, endosomal release, and nuclear entry, all while preserving cell health and morphology.

This reagent supports both transient and stable transfection workflows, and its compatibility with multi-well formats makes it suitable for high-throughput screening or complex co-transfection experiments. The included protocol minimizes the need for additional optimization, allowing for rapid implementation and consistent performance across replicates.

Applications in Functional Genomics and Therapeutic Discovery

Transfecting NCI-H23 cells enables detailed study of gene function in the context of lung adenocarcinoma. Researchers can silence or overexpress target genes to analyze their role in cellular proliferation, apoptosis, immune evasion, and drug sensitivity. The reagent is suitable for applications involving siRNA-mediated knockdown, CRISPR-Cas9 genome editing, transcription factor assays, and reporter gene studies.

NCI-H23 cells are often used to investigate resistance to EGFR inhibitors, regulation of tumor suppressor genes, and activation of oncogenic signaling pathways. Transfection tools that function reliably in this cell line are essential for generating reproducible preclinical data and advancing therapeutic strategies for NSCLC.

Read More Information: NCI-H23 Transfection Reagent

Request Quote here: https://altogen.com/request-quote/

NCI-H1299 Transfection Kit (Lung Adenocarcinoma)

Relevance of NCI-H1299 in Lung Cancer Research

NCI-H1299 cells are a well-characterized human lung adenocarcinoma line notable for their lack of endogenous p53 expression. This makes them particularly useful for studies investigating p53 signaling, apoptosis, and DNA damage response pathways. Their epithelial morphology, strong proliferative capacity, and genetic stability make them one of the most widely used cell lines in non-small cell lung cancer research.

NCI-H1299 cells are frequently used in experiments involving cell cycle regulation, oncogene-driven signaling, and drug resistance profiling. Because of their p53-null background, they serve as a powerful tool for assessing how p53 restoration or modulation of related pathways affects tumor cell behavior. Transfection plays a critical role in these studies, allowing direct manipulation of genes and pathways of interest.

Overcoming Transfection Barriers

Transfecting epithelial carcinoma cells such as NCI-H1299 requires reagents that offer efficient delivery without compromising cell viability or function. The NCI-H1299 Transfection Kit addresses this challenge by combining a proprietary lipid carrier with a protocol optimized for the physiological properties of this cell line. This enables high intracellular uptake, efficient endosomal escape, and minimal cellular stress, ensuring strong transgene expression or knockdown with consistent results.

Altogen’s cell-type–specific formulation eliminates the need for time-consuming reagent optimization and is compatible with multiple assay formats, from small-scale transfections to high-throughput screening. Researchers benefit from both ease of use and reproducibility across experimental replicates.

Functional Applications in Oncological Studies

NCI-H1299 cells are used to explore a wide spectrum of cancer-related pathways including EGFR signaling, Ras/MAPK cascades, and epithelial-to-mesenchymal transition. Transfection of these cells supports diverse experimental goals—from overexpressing tumor suppressors and testing dominant-negative mutants to performing genome-wide siRNA screens.

Their responsiveness to chemotherapeutic agents and targeted compounds also makes them valuable in drug sensitivity studies and synthetic lethality investigations. Genetic manipulation of NCI-H1299 cells using a reliable transfection kit allows researchers to dissect molecular dependencies, evaluate candidate therapeutic targets, and generate models of drug resistance.

Read More Information: NCI-H1299 Transfection Kit

Request Quote here: https://altogen.com/request-quote/

NCI-H1975 Transfection Kit (Lung Carcinoma)

Significance of NCI-H1975 in NSCLC Research

NCI-H1975 is a human lung adenocarcinoma cell line known for its relevance to targeted therapy resistance. It harbors both the L858R activating mutation and the T790M resistance mutation in the epidermal growth factor receptor (EGFR) gene. These genetic alterations make the cell line a key model for evaluating mechanisms of resistance to EGFR tyrosine kinase inhibitors and developing next-generation therapeutic strategies.

The molecular characteristics of NCI-H1975 cells have led to their widespread use in functional genomics, targeted therapy validation, and translational oncology research. Transfecting these cells allows for detailed interrogation of signaling networks such as EGFR, PI3K/Akt, and MAPK, as well as the discovery of synthetic lethal interactions and pathways involved in resistance reversal.

Optimized Gene Delivery for Challenging Cell Types

Like many epithelial-derived carcinoma lines, NCI-H1975 cells can be sensitive to chemical perturbation and may exhibit variable transfection efficiency with general-purpose reagents. The NCI-H1975 Transfection Kit is formulated to address these limitations by enhancing membrane interaction, nucleic acid encapsulation, and endosomal escape, resulting in high gene expression or silencing with low toxicity.

The reagent works efficiently in standard culture conditions and supports both transient and stable transfection workflows. Its compatibility with high-throughput formats makes it ideal for screening assays, pathway analysis, and co-transfection studies.

Applications in Targeted Therapy and Resistance Research

NCI-H1975 cells are a critical tool in modeling acquired resistance to EGFR inhibitors, a common clinical problem in NSCLC treatment. Transfection enables researchers to modify or silence genes that influence cellular response to small-molecule inhibitors, immune checkpoint agents, or novel drug combinations. This includes evaluating compensatory signaling routes, transcription factor activity, and feedback loops that emerge during treatment.

Additionally, transfection in NCI-H1975 cells supports studies in apoptosis regulation, autophagy, and EMT, providing insight into tumor plasticity and adaptation. As a model that closely resembles resistant patient-derived tumors, NCI-H1975 is essential for bridging basic research and preclinical development.

Read More Information: NCI-H1975 Transfection Kit

Request Quote here: https://altogen.com/request-quote/

NCI-H460 Transfection Kit (Lung Carcinoma, HTB177)

Importance of NCI-H460 Cells in Lung Cancer Research

NCI-H460 cells are derived from a large cell lung carcinoma and are commonly used as a model of NSCLC. They are known for their high proliferation rate, epithelial morphology, and wild-type p53 status. These properties make NCI-H460 cells highly relevant for research into tumor suppressor pathways, cell cycle regulation, metabolism, and therapeutic resistance mechanisms.

As a genetically stable and tumorigenic cell line, NCI-H460 is often utilized in both 2D monolayer cultures and 3D spheroid systems to investigate drug efficacy, apoptosis signaling, and metastatic potential. The ability to manipulate gene expression through transfection is critical for functional studies in this model system, supporting applications such as RNA interference, CRISPR genome editing, and pathway-specific overexpression.

Optimized Delivery and Low Cytotoxicity

Transfecting fast-growing carcinoma cells like NCI-H460 can be challenging due to their sensitivity to chemical stress and their membrane properties. The NCI-H460 Transfection Kit by Altogen Biosystems is engineered to overcome these challenges. Its lipid-based formulation enhances cellular uptake and promotes efficient endosomal escape, ensuring successful gene transfer while preserving cell viability and morphology.

The kit includes a cell-specific protocol, eliminating the need for trial-and-error optimization. It is suitable for both short-term gene expression studies and long-term experiments requiring stable cell line development. Researchers benefit from consistent results across replicates, enabling precise experimental control and robust data generation.

Applications in Oncogenic Pathway Analysis and Drug Discovery

Transfection of NCI-H460 cells enables targeted investigation of genes and signaling pathways implicated in lung cancer progression. These cells are frequently used to explore mechanisms of tumor suppression, resistance to chemotherapy, mitochondrial dynamics, and metabolic adaptation. Introducing genetic constructs through transfection allows for the functional analysis of candidate genes, identification of druggable targets, and development of predictive biomarkers.

In therapeutic development, NCI-H460 cells are often employed to test responses to DNA-damaging agents, targeted inhibitors, and combination therapies. Transfection technologies are essential for validating mechanistic hypotheses, generating engineered cell lines, and modeling complex tumor biology.

Read More Information: NCI-H460 Transfection Kit

Request Quote here: https://altogen.com/request-quote/

Calu-6 Transfection Kit (Lung Carcinoma, HTB-56)

Calu-6 as a Model for Lung Carcinoma

Calu-6 cells are derived from human anaplastic lung carcinoma and are commonly used in research focused on poorly differentiated non-small cell lung tumors. Unlike other NSCLC models, Calu-6 cells lack functional p53 protein and exhibit a mesenchymal-like phenotype, making them highly suitable for studying tumor aggressiveness, metastasis, and resistance to therapy. These characteristics allow researchers to explore oncogenic pathways involved in epithelial-to-mesenchymal transition (EMT), invasive behavior, and treatment adaptation.

Their expression profile includes genes related to cell motility, matrix remodeling, and transcriptional reprogramming, and the cell line is frequently used in experiments focused on tumor progression, immunomodulation, and experimental drug testing.

Optimized Transfection for Difficult-to-Modify Cells

Poorly differentiated lung cancer cells like Calu-6 are known to be challenging to transfect due to their atypical morphology, variable membrane composition, and sensitivity to environmental stress. The Calu-6 Transfection Kit by Altogen Biosystems addresses these challenges with a proprietary lipid formulation that improves membrane interaction, promotes endosomal escape, and ensures reliable nuclear delivery of nucleic acids.

This kit is designed to provide high transfection efficiency with minimal cytotoxic effects, preserving cellular function and viability. The included protocol is straightforward and optimized for Calu-6 cells, eliminating the need for extended troubleshooting or reagent adaptation. Researchers benefit from reproducible performance in both short-term and long-term gene modulation experiments.

Applications in Tumor Biology and Therapy Development

Transfection of Calu-6 cells is essential for studying genes associated with high-grade NSCLC and resistance phenotypes. Gene knockdown and overexpression experiments help researchers identify molecular drivers of proliferation, immune evasion, and treatment resistance. Calu-6 cells are also used to model tumor plasticity and mesenchymal transformation, providing insight into how tumor cells adapt in response to environmental pressure or therapeutic intervention.

In drug development pipelines, Calu-6 serves as a preclinical model for evaluating investigational agents targeting EMT pathways, DNA repair mechanisms, and immune checkpoint regulation. Transfection enables the construction of custom experimental conditions that mimic real-world tumor complexity, advancing therapeutic discovery and biomarker validation.

Read More Information: Calu-6 Transfection Kit

Request Quote here: https://altogen.com/request-quote/

Calu-3 Transfection Kit (Lung Carcinoma, HTB-55)

Relevance of Calu-3 Cells in Respiratory and Oncological Studies

Calu-3 cells are derived from human lung adenocarcinoma and exhibit a highly differentiated epithelial phenotype. These cells are particularly valued for their ability to form tight junctions and polarized monolayers, closely mimicking the structure and function of airway epithelial tissue. Because of this, Calu-3 cells are widely used in respiratory research to study airway barrier function, mucosal immunity, drug absorption, and epithelial response to environmental agents.

In addition to their role in pulmonary biology, Calu-3 cells are used in cancer research to investigate lung tumorigenesis, immune signaling, and cellular differentiation. Their ability to maintain epithelial characteristics makes them useful for modeling early-stage tumor behavior and epithelial-specific responses to genetic or pharmacological manipulation.

Enhanced Transfection Efficiency and Minimal Cytotoxicity

Transfection of Calu-3 cells can be challenging due to their tight junction formation and high cell density, which can limit reagent access and nucleic acid uptake. The Calu-3 Transfection Kit from Altogen Biosystems is engineered to overcome these barriers through a proprietary lipid formulation that enhances delivery efficiency and endosomal release. This formulation supports robust gene expression or knockdown while maintaining the integrity and function of epithelial monolayers.

Altogen’s kit includes an optimized, ready-to-use protocol that eliminates the need for time-consuming optimization. It supports both transient and stable transfection workflows and is compatible with various culture formats including Transwell systems, commonly used for air–liquid interface studies.

Applications in Lung Barrier Biology and Cancer Research

Calu-3 cells are instrumental in studying epithelial barrier permeability, transport mechanisms, and host–pathogen interactions. Transfection allows precise genetic manipulation to assess the function of transporters, cytokines, and adhesion molecules critical to maintaining lung barrier integrity. These capabilities are essential for evaluating new inhaled therapeutics and understanding how environmental toxins affect respiratory epithelium.

In oncology, transfection of Calu-3 cells provides a platform for exploring genes that regulate cell polarity, tumor suppression, and growth factor signaling. These studies help clarify the molecular events involved in lung cancer initiation and progression. Genetic modulation using siRNA, CRISPR, or overexpression constructs allows researchers to dissect the functional roles of specific targets in a controlled, epithelial cell context.

Read More Information: Calu-3 Transfection Kit

Request Quote here: https://altogen.com/request-quote/

3LL Transfection Reagent (Lewis Lung Carcinoma)

Scientific Relevance of 3LL Cells

3LL cells are derived from a spontaneously arising murine lung carcinoma and are widely used in both in vitro and in vivo studies of lung cancer biology. These cells are known for their high tumorigenicity and metastatic potential when implanted into syngeneic mouse models, making them a cornerstone of experimental lung cancer research. They are particularly valuable for investigating tumor-host interactions, immune evasion, angiogenesis, and the metastatic cascade.

In vitro, 3LL cells serve as a robust model for studying proliferation, apoptosis, epithelial–mesenchymal transition (EMT), and response to genotoxic agents. Their use in immunocompetent mouse models allows for comprehensive evaluation of tumor development and therapeutic responses in a system that includes an intact immune microenvironment.

Optimized Gene Delivery in a Preclinical Lung Cancer Model

Effective transfection of 3LL cells can be difficult due to their rapid proliferation and species-specific membrane composition. The 3LL Transfection Reagent by Altogen Biosystems is engineered to overcome these challenges with a proprietary lipid formulation that enhances nucleic acid uptake and ensures efficient release into the cytoplasm. The result is a significant increase in transgene expression or gene knockdown, achieved with minimal cytotoxicity and without compromising cell morphology.

The included protocol is optimized for 3LL cells and supports both transient and stable transfection workflows. This allows researchers to conduct short-term gene expression studies or develop genetically modified lines for long-term experimentation, including in vivo xenograft and syngeneic models.

Applications in Lung Cancer and Immuno-Oncology Research

Transfecting 3LL cells enables the study of oncogenic signaling pathways, resistance mechanisms, and immune-regulatory genes in a context that closely resembles in vivo tumor biology. These cells are commonly used to evaluate experimental immunotherapies, test the function of tumor suppressors and oncogenes, and model the interaction between tumor cells and the host immune system.

Genetic manipulation of 3LL cells via transfection supports a wide range of experimental objectives, from validating therapeutic targets to assessing the impact of gene silencing or overexpression on tumor behavior. In immuno-oncology, these cells are critical for understanding tumor immune evasion, inflammatory signaling, and checkpoint pathway dynamics within an immunocompetent system.

Read More Information: 3LL Transfection Reagent

Request Quote here: https://altogen.com/request-quote/

IMR-90 Transfection Kit (Lung Fibroblast, CCL186)

Importance of IMR-90 Cells in Pulmonary and Aging Research

IMR-90 is a diploid fibroblast cell line derived from normal human lung tissue and has become a cornerstone model for studying normal lung cell physiology, cellular senescence, DNA damage response, and lung-related diseases. As non-transformed primary-like cells, IMR-90 cells retain a finite replicative lifespan, making them particularly useful in aging and oxidative stress research. They are also employed in respiratory toxicology, fibrosis modeling, and cellular response studies involving environmental exposure and chemical insult.

These cells are known for their stable karyotype and human origin, which makes them highly relevant for translational studies aiming to understand the behavior of normal lung fibroblasts in contrast to malignant or immortalized cell types. Their sensitivity to genotoxic stress and well-defined senescence-associated phenotype make them an invaluable tool for evaluating gene function in the context of cellular aging and disease progression.

Transfection Challenges and Altogen’s Optimized Solution

Primary-like fibroblasts such as IMR-90 are notoriously difficult to transfect due to their sensitivity to lipid-based reagents, tendency to enter growth arrest under stress, and strong adherence to the culture surface. The IMR-90 Transfection Kit by Altogen Biosystems addresses these challenges with a proprietary lipid formulation that promotes effective nucleic acid delivery while preserving cell viability and normal function.

The optimized protocol included in the kit ensures consistent results across experiments with minimal need for adjustment. Whether performing transient knockdown studies or introducing expression vectors for long-term analysis, this kit delivers reliable performance while maintaining the delicate balance of fibroblast homeostasis.

Applications in Lung Biology, Fibrosis, and Aging Studies

Transfecting IMR-90 cells allows for the modulation of genes involved in lung matrix remodeling, senescence pathways, cytokine signaling, and cell cycle regulation. These cells are widely used in experiments that investigate the molecular basis of idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease, and other age-related degenerative lung conditions.

Gene silencing and overexpression in IMR-90 cells enable researchers to dissect complex signaling networks such as TGF-β/SMAD, p53/p21, and inflammatory cascades that drive fibroblast activation and extracellular matrix deposition. Additionally, these cells support toxicological studies that evaluate DNA repair capacity, oxidative damage, and transcriptional responses to stressors such as cigarette smoke or particulate matter.

Read More Information: IMR-90 Transfection Kit

Request Quote here: https://altogen.com/request-quote/

NCI-H292 Transfection Kit (Lung Carcinoma, CRL1848)

Role of NCI-H292 Cells in Lung and Mucosal Biology Research

NCI-H292 cells are derived from a mucoepidermoid lung carcinoma and are uniquely characterized by their ability to secrete mucins and express markers of airway epithelial differentiation. This cell line is widely used in studies of mucosal biology, pulmonary inflammation, respiratory infection, and mucin regulation. Its dual relevance in oncology and airway epithelial research makes NCI-H292 a versatile platform for understanding lung tumor progression and the biology of secretory epithelium.

Researchers use NCI-H292 cells to model the cellular responses of airway epithelium to cytokines, allergens, pathogens, and environmental exposures. In lung cancer research, they serve as a system for studying growth factor signaling, epithelial-to-mesenchymal transition (EMT), and the regulation of oncogenes and tumor suppressors.

Cell-Type Optimized Transfection for Consistent Results

Epithelial carcinoma cells like NCI-H292 are known for their tight junctions and secretory phenotype, both of which can impede transfection efficiency with generic reagents. The NCI-H292 Transfection Kit by Altogen Biosystems is tailored to overcome these challenges through a proprietary lipid formulation that enhances nucleic acid uptake, promotes endosomal escape, and delivers genetic cargo with minimal cytotoxicity.

This reagent is ideal for both high-throughput screening and single-gene functional studies, and its optimized protocol simplifies workflow by eliminating the need for complex reagent adjustment. Researchers gain the ability to introduce and study gene function with precision and consistency in a cell line known for its biological complexity.

Applications in Inflammation, Cancer, and Barrier Function Studies

Transfecting NCI-H292 cells supports research into the regulation of mucin genes such as MUC5AC and MUC1, which are key to understanding diseases like asthma, chronic bronchitis, and lung cancer. Gene knockdown or overexpression experiments enable exploration of inflammatory signaling pathways, including those mediated by TNF-α, IL-13, and EGFR. NCI-H292 cells are also valuable for studying oxidative stress responses, epithelial repair mechanisms, and transcription factor activation.

In cancer-focused applications, this cell line is used to evaluate drug response, identify regulators of epithelial identity, and validate therapeutic targets. Transfection technologies make it possible to probe these functions in depth, enabling development of more effective treatment strategies for both neoplastic and non-neoplastic lung diseases.

Read More Information: NCI-H292 Transfection Kit

Request Quote here: https://altogen.com/request-quote/